StockData
Milestone Pharmaceuticals Inc. logo

Milestone Pharmaceuticals Inc. (MIST) stock

MISTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.46+0.05 (+11.42%)

Close on Nov 18, 2026Market cap $57.32MP/E –Yield –

Milestone Pharmaceuticals shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Milestone Pharmaceuticals's shares outstanding was 41M at Mar 31, 2021. For fiscal 2020 it was 29M, up 85.9% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2020Dec 31, 202029M+85.9%
FY2019Dec 31, 201916M+4845.1%
FY2018Dec 31, 20180M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2021Mar 31, 202141M+68.1%
Q4 FY2020Dec 31, 202038M+56.1%
Q3 FY2020Sep 30, 202030M+21.6%
Q2 FY2020Jun 30, 202025M+86.7%
Q1 FY2020Mar 31, 202025M+3970.8%
Q4 FY2019Dec 31, 201925M+5450.5%
Q3 FY2019Sep 30, 201924M+8561.0%
Q2 FY2019Jun 30, 201913M+4572.2%
Q1 FY2019Mar 31, 20191M+124.6%
Q4 FY2018Dec 31, 20180M–
Q3 FY2018Sep 30, 20180M–
Q2 FY2018Jun 30, 20180M–
Q1 FY2018Mar 31, 20180M–

More Milestone Pharmaceuticals figures

See a number that looks wrong?